This is a competing renewal of a postdoctoral training program entitled """"""""Training in the Pathogenesis of Infectious Diseases."""""""" The program based in the Infectious Diseases Section of the Department of Internal Medicine at the Yale University School of Medicine. The program's overall goal is to produce outstanding physician-scientists who use modern laboratory research methods to study human infectious diseases. The program is designed primarily for M.D.'s and M.D./Ph.D.'s who have completed their subspecialty clinical training in the Infectious Diseases fellowship program at Yale, but selected M.D.'s or M.D./Ph.D.'s with clinical training in other fields will also be eligible to participate. The training faculty consists of (i) 16 laboratory-based researchers from two clinical (Medicine and Pediatrics) and three basic science (Microbial Pathogenesis, Cell Biology and Immunobiology) Departments or Sections and (ii) 3 experts in clinical epidemiology and patient-oriented research from the Departments of Medicine and Pediatrics. Each trainee will be supervised by two co-mentors, and their progress will be monitored by Training Committees. The trainees will have access to several new programs and facilities at Yale, including the recently-established Section of Microbial Pathogenesis, an innovative new Investigative Medicine Ph.D. Program for M.D.'s who have completed their clinical training, and a state-of-the-art laboratory research building that has just been completed on the Yale Medical School campus. We are confident that this Program will provide its trainees with outstanding opportunities to pursue careers in infectious diseases research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI007517-08
Application #
7091458
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Mcsweegan, Edward
Project Start
1997-07-01
Project End
2009-06-30
Budget Start
2006-07-01
Budget End
2007-06-30
Support Year
8
Fiscal Year
2006
Total Cost
$276,320
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Datta, Rupak; Advani, Sonali; Rink, Andrea et al. (2018) Frequency of Infection during Fever Episodes among Long-Term Care Residents. J Gerontol Geriatr Res 7:
Datta, Rupak; McManus, Dayna; Topal, Jeffrey et al. (2018) Long-Acting Lipoglycopeptides for Gram-Positive Bacteremia at the End of Life to Facilitate Hospice Care: A Report of 3 Cases. Open Forum Infect Dis 5:ofx277
Nance, Robin M; Delaney, J A Chris; Golin, Carol E et al. (2017) Co-calibration of two self-reported measures of adherence to antiretroviral therapy. AIDS Care 29:464-468
Nathavitharana, Ruvandhi R; Cudahy, Patrick G T; Schumacher, Samuel G et al. (2017) Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis. Eur Respir J 49:
Kanamori, Hajime; Parobek, Christian M; Juliano, Jonathan J et al. (2017) A Prolonged Outbreak of KPC-3-Producing Enterobacter cloacae and Klebsiella pneumoniae Driven by Multiple Mechanisms of Resistance Transmission at a Large Academic Burn Center. Antimicrob Agents Chemother 61:
Strassle, Paula D; Williams, Felicia N; Napravnik, Sonia et al. (2017) Improved Survival of Patients With Extensive Burns: Trends in Patient Characteristics and Mortality Among Burn Patients in a Tertiary Care Burn Facility, 2004-2013. J Burn Care Res 38:187-193
Meyer, Jaimie P; Muthulingam, Dharushana; El-Bassel, Nabila et al. (2017) Leveraging the U.S. Criminal Justice System to Access Women for HIV Interventions. AIDS Behav 21:3527-3548
Thaden, Joshua T; Park, Lawrence P; Maskarinec, Stacey A et al. (2017) Results from a 13-Year Prospective Cohort Study Show Increased Mortality Associated with Bloodstream Infections Caused by Pseudomonas aeruginosa Compared to Other Bacteria. Antimicrob Agents Chemother 61:
Springer, Sandra A; Di Paola, Angela; Azar, Marwan M et al. (2017) Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community. Drug Alcohol Depend 174:158-170
Gonzalez, Daniel; Bradley, John S; Blumer, Jeffrey et al. (2017) Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age. Pediatr Infect Dis J 36:645-653

Showing the most recent 10 out of 65 publications